Curaphyx offers a UK pharmacy weight loss service. This page explains overweight and obesity, the treatments available in the UK, and how our consultation works, so you can decide whether to start. A prescription medicine is supplied only if a UK-registered prescriber decides it is appropriate for you. Wanting to lose weight is not, on its own, enough for a prescription. Medicines are always used alongside a reduced-calorie diet and more physical activity.

Overweight and obesity

Overweight and obesity mean having more body fat than your body needs. Over time, this can raise the risk of serious health problems. The NHS lists type 2 diabetes, heart disease, stroke, high blood pressure, some cancers, osteoarthritis and fatty liver disease. Day to day, it can also cause breathlessness, tiredness, joint and back pain, snoring and low mood. The NHS says that losing even a small amount of weight, 5 to 10% of your body weight, can improve your health.

Body mass index (BMI) and waist size

BMI uses your height and weight to estimate whether your weight is healthy. For most adults, the NHS uses these ranges:
  • 25 to 29.9: overweight
  • 30 or more: obese
If you are from a South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background, health risks start at a lower BMI:
  • 23 to 27.4: overweight
  • 27.5 or more: obese
BMI can’t tell muscle from fat, so it isn’t the whole picture. If your BMI is under 35, the NHS suggests also checking your waist-to-height ratio. Aim to keep your waist measurement to less than half your height.

Who this service is for

This service is for adults who want clinical advice on weight management and may be considered for prescription treatment after assessment. A clinician will consider:
  • your weight, height and BMI, which we verify
  • weight-related health conditions, such as type 2 diabetes, prediabetes, high blood pressure, high cholesterol, sleep apnoea or heart disease
  • your medical history and all the medicines and supplements you take
  • whether a licensed treatment could be suitable and safe for you
The licences for semaglutide (Wegovy injection and tablets), tirzepatide (Mounjaro), liraglutide (Saxenda) and orforglipron (Foundayo) cover adults with a BMI of 30 or more, or a BMI of 27 to under 30 with at least one weight-related health condition. Orlistat has different BMI criteria (see below). A prescriber applies these to you individually. This service is not suitable if you are pregnant, trying to become pregnant or breastfeeding. Tell us if you have a history of an eating disorder, recent rapid weight change, pancreatitis, gallbladder disease, or severe stomach or bowel disease.

Lifestyle comes first

Medicines don’t replace healthy habits. The NHS advises:
  • eating a balanced diet with fewer calories, cutting down on high-fat and sugary foods, and eating plenty of fruit and vegetables
  • losing weight steadily, at around 0.5 to 1 kg (1 to 2 lb) a week
  • cutting down on alcohol, which is high in calories
  • being active for 45 to 60 minutes a day, which you can split into shorter sessions
  • setting realistic goals and weighing yourself regularly
  • being kind to yourself, because changing habits takes time
On average, women use around 2,000 calories a day and men around 2,500. Free support is available through NHS Better Health and local weight management programmes, and the NHS says you can refer yourself to some of them.

Weight loss medicines in the UK

The NHS describes two main ways weight loss medicines work. Some reduce your appetite and help you feel fuller for longer (GLP-1 and GIP medicines). Others stop your body absorbing as much fat from food (orlistat). Medicines are prescribed alongside diet and activity advice. When you stop, you should be offered support to help keep the weight off.

Wegovy (semaglutide)

Semaglutide is a GLP-1 medicine. Wegovy injection is given once a week under the skin, using a pre-filled pen. Treatment starts at 0.25 mg and is increased over 16 weeks to a maintenance dose of 2.4 mg, to reduce stomach side effects. A prescriber may increase it further in some people with obesity. Wegovy tablets (oral semaglutide) were authorised by the MHRA in June 2026 for weight management. They are taken once a day on an empty stomach, after a fast of at least 8 hours, with a sip of water. The dose starts at 1.5 mg and increases step by step, with at least a month at each dose, to a maintenance dose of 25 mg. See the patient leaflet for when you can eat and drink afterwards.

Foundayo (orforglipron)

Orforglipron is a GLP-1 medicine taken as a tablet once a day. It was authorised by the MHRA in August 2026 for weight management. It can be taken at any time of day, with no food or water restrictions. The dose starts at 0.8 mg and is increased step by step, with at least 30 days at each dose. See the patient leaflet.

Mounjaro (tirzepatide)

Tirzepatide acts on two hormone receptors, GIP and GLP-1. It is given as a once-weekly injection under the skin. The starting dose is 2.5 mg. After 4 weeks it increases to 5 mg, and if needed it can be increased in 2.5 mg steps, at least 4 weeks apart, up to a maximum of 15 mg.

Liraglutide (Saxenda and others)

Liraglutide is a GLP-1 medicine given as a once-daily injection. It starts at 0.6 mg and increases in 0.6 mg steps, at least a week apart, to 3.0 mg.

Orlistat (Xenical, Alli)

Orlistat reduces how much fat your body absorbs from food. It is taken as a capsule with each main meal, up to three times a day, and the dose is skipped if a meal is missed or contains no fat. Orlistat 120 mg (Xenical and generic orlistat) is a prescription medicine for adults with a BMI of 30 or more, or 28 or more with other risk factors. Orlistat 60 mg (Alli) is a pharmacy medicine for adults with a BMI of 28 or more. It is taken alongside a balanced, mildly reduced-calorie diet with about 30% of calories from fat.

Comparing weight loss medicines

This table summarises the licensed product information for each medicine. It does not suggest that one is better than another. Results and side effects vary, and a prescriber decides whether any medicine is suitable for you.
Brand Generic name Medicine type How it’s taken How often Legal status
Wegovy semaglutide GLP-1 injection under the skin (pen) once a week POM
Wegovy tablets semaglutide GLP-1 tablet, on an empty stomach once a day POM
Foundayo orforglipron GLP-1 tablet, no food restrictions once a day POM
Mounjaro tirzepatide GIP/GLP-1 injection under the skin (pen) once a week POM
Saxenda liraglutide GLP-1 injection under the skin (pen) once a day POM
Xenical orlistat 120 mg lipase inhibitor capsule with meals up to 3 times a day POM
Alli orlistat 60 mg lipase inhibitor capsule with meals up to 3 times a day P
Doses, dose increases and how long treatment continues are set out in each medicine’s patient leaflet.

Weight loss medicines on the NHS

NICE has published technology appraisal guidance on semaglutide (TA875) and tirzepatide (TA1026) for managing overweight and obesity on the NHS. Who can get them depends on criteria set by NICE and on local services. Wegovy tablets and Foundayo are not currently available on the NHS for weight loss, pending NICE assessment. Your GP can tell you what is available in your area.

What treatment may involve

The prescriber decides whether a medicine is appropriate, which licensed option and which strength. That decision is individual. It is not made from a product grid. No outcome is guaranteed. How you respond, what side effects you have and how long treatment continues all vary. Read the patient information leaflet supplied with your medicine.

Side effects and safety

The most common side effects of GLP-1 and GIP medicines affect the stomach and gut. They include feeling or being sick, diarrhoea, constipation and stomach pain, which is why doses are increased gradually. See the patient leaflet. Get medical help straight away if you have:
  • persistent, severe stomach pain, because this can be a sign of an inflamed pancreas (pancreatitis)
  • signs of gallbladder problems, such as gallstones (see the patient leaflet for symptoms)
  • signs of a serious allergic reaction
  • signs of dehydration, such as being very thirsty or passing little urine, after vomiting or diarrhoea
Other important points:
  • Contraception: tirzepatide and orforglipron may make the contraceptive pill less reliable. Their product information advises switching to a non-oral method, or adding a barrier method, for 4 weeks (tirzepatide) or 30 days (orforglipron) after starting and after each dose increase.
  • Pregnancy and breastfeeding: these medicines should not be used in pregnancy. Semaglutide should be stopped at least 2 months before a planned pregnancy and should not be used while breastfeeding. For other medicines, see the patient leaflet.
  • Diabetes medicines: tell us if you take insulin or a sulfonylurea, because low blood sugar is more likely.
  • Surgery: tell your anaesthetist that you use one of these medicines before any operation or deep sedation, because there is a risk of breathing food or fluid into the lungs.
  • Orlistat: common side effects include oily spotting, fatty or oily stools and needing to go urgently. It may reduce absorption of vitamins A, D, E and K. See the patient leaflet.

Buying weight loss medicines safely

Only get these medicines on prescription from a UK-registered pharmacy. You can check any pharmacy on the GPhC register. Don’t use pens or tablets from unregulated sellers, such as social media accounts or beauty salons, because you can’t be sure what they contain.

How the Curaphyx service works

  1. Consultation. Complete a consultation questionnaire honestly.
  2. Checks. Provide the identity and body-measurement checks we ask for.
  3. Prescriber review. A UK-registered prescriber reviews your information.
  4. Decision. If treatment is not suitable, we’ll tell you and won’t supply a prescription medicine.
  5. Treatment and follow-up. If treatment is offered, you receive clear instructions, the patient leaflet and regular follow-up.
Medicines are dispatched only after clinical approval. Where next-day delivery is offered, it applies to approved orders only.

When to get advice before you start

Ask a pharmacist or prescriber before starting a consultation if you:
  • have a long-term condition, such as diabetes, thyroid, gallbladder, kidney or liver disease
  • take other prescription or pharmacy medicines
  • have had pancreatitis or serious digestive problems
  • have a history of disordered eating
  • are planning a pregnancy
If you feel unwell after any treatment you’ve been prescribed, follow the patient information leaflet and seek medical help. For urgent symptoms, use NHS 111 or call 999 in an emergency.

If you are not offered prescription treatment

That is a clinical decision, not a sales decision. You can still ask a Curaphyx pharmacist about pharmacy weight management products where they are appropriate, and about diet and activity advice. Your GP can tell you about NHS weight management programmes in your area.

Privacy and professional standards

Consultations are reviewed by UK-registered clinicians. Your information is used only to assess suitability and to supply medicines safely. Packaging is discreet. Return unused medicines to a pharmacy, and put used pens and needles in a sharps bin rather than household rubbish.

FAQs

Who can get weight loss treatment?

Adults whose BMI and health history meet the criteria in a medicine’s licence may be considered. For semaglutide, tirzepatide, liraglutide and orforglipron, that is a BMI of 30 or more, or 27 to under 30 with at least one weight-related health condition. A prescriber decides whether treatment is suitable for you.

How do weight loss injections work?

Semaglutide and tirzepatide mimic natural gut hormones. They help reduce appetite and help you feel fuller for longer. They are used alongside a reduced-calorie diet and more physical activity.

What is the difference between semaglutide and tirzepatide?

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both the GIP and GLP-1 receptors. Both are once-weekly injections with a gradual dose increase. A prescriber decides whether either is suitable for you.

Are there tablet options for weight loss?

Yes. Semaglutide tablets (Wegovy) and orforglipron tablets (Foundayo) are once-daily prescription medicines, and orlistat capsules are taken with meals. Each has its own rules on who can use it and how to take it. See the patient leaflet.

What are the common side effects?

The most common side effects of weight loss injections are feeling or being sick, diarrhoea, constipation and stomach pain, especially when starting or increasing the dose. Get urgent help for severe, persistent stomach pain.

Do I still need to diet and exercise?

Yes. Weight loss medicines are licensed for use alongside a reduced-calorie diet and more physical activity. They do not replace healthy habits.

What happens when I stop treatment?

Talk to your prescriber before you stop. The NHS says that after you stop taking weight loss medicines, you should be offered support to help you stay a healthy weight.

Can I use weight loss medicines if I’m pregnant or breastfeeding?

No. These medicines should not be used during pregnancy, and semaglutide should not be used while breastfeeding. If you plan to become pregnant, speak to your prescriber, as treatment needs to stop beforehand.

How do I dispose of used pens and needles?

Put used pens and needles in a sharps bin, not household rubbish. Ask your pharmacy how to return a full sharps bin.

Why might I not be offered a prescription?

A prescriber may decide a medicine isn’t safe or suitable, for example because of your BMI, health conditions or other medicines. If so, we’ll explain why and suggest other support.

Sources

Medically reviewed by [Pharmacist name], GPhC [number], on [date]. Next review due: [date]. Curaphyx is a GPhC-registered pharmacy, premises number [number].